These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2046075)

  • 21. [Progestins and arterial disease].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):344-52. PubMed ID: 12280205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contraception for the diabetic woman].
    Arlot S; Mesmacque A; Lalau JD; Quichaud J
    Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral contraception and carbohydrate metabolism: III--practical implications].
    Hilal M
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic impact of oral contraceptives.
    Krauss RM; Burkman RT
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral contraception and coronary heart disease.
    Oliver MF
    Eur Heart J; 1983 Jan; 4(1):6-8. PubMed ID: 6832178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral contraceptives and the risk of cardiovascular disease.
    Med Lett Drugs Ther; 1983 Jul; 25(640):69-70. PubMed ID: 6865850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of the androgenicity of progestins in hormonal therapy in women.
    Linn ES
    Clin Ther; 1990; 12(5):447-55. PubMed ID: 2268868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives and lipoprotein metabolism.
    Tikkanen MJ; Nikkilä EA
    J Reprod Med; 1986 Sep; 31(9 Suppl):898-905. PubMed ID: 3772909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptives.
    Shearman RP
    Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OC practice guidelines: minimizing side effects.
    Darney PD
    Int J Fertil Womens Med; 1997; Suppl 1():158-69. PubMed ID: 9168375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sex steroids and vascular risk].
    Rozenbaum H
    Coeur; 1983; 14(1):91-102. PubMed ID: 12339512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.